ZA988729B - The use of an inhibitor of the Na/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system - Google Patents

The use of an inhibitor of the Na/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system

Info

Publication number
ZA988729B
ZA988729B ZA988729A ZA988729A ZA988729B ZA 988729 B ZA988729 B ZA 988729B ZA 988729 A ZA988729 A ZA 988729A ZA 988729 A ZA988729 A ZA 988729A ZA 988729 B ZA988729 B ZA 988729B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
medicament
disorders
exchanger
inhibitor
Prior art date
Application number
ZA988729A
Inventor
Hans Jochen Lang
Klaus Wirth
Dieter Bingmann
Udo Bonnet
Martin Wiemann
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of ZA988729B publication Critical patent/ZA988729B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA988729A 1997-09-24 1998-09-23 The use of an inhibitor of the Na/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system ZA988729B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742096A DE19742096A1 (en) 1997-09-24 1997-09-24 Use of sodium/hydrogen ion exchanger inhibitor to treat and prevent central nervous system disorders, e.g. epilepsy and psychotic disorders

Publications (1)

Publication Number Publication Date
ZA988729B true ZA988729B (en) 1999-03-24

Family

ID=7843446

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA988729A ZA988729B (en) 1997-09-24 1998-09-23 The use of an inhibitor of the Na/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system

Country Status (3)

Country Link
DE (1) DE19742096A1 (en)
PL (1) PL328842A1 (en)
ZA (1) ZA988729B (en)

Also Published As

Publication number Publication date
DE19742096A1 (en) 1999-03-25
PL328842A1 (en) 1999-03-29

Similar Documents

Publication Publication Date Title
HK1008180A1 (en) Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
GB2305605B (en) Pipecolic acid derivatives for the treatment of neurological disorders
IL121170A0 (en) Compositions for the treatment of dermatological disorders
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
HU0003863D0 (en) Alpha-sulfonylamino hidroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
EP1063990A4 (en) Therapy of estrogen-associated disorders
HUP0001777A3 (en) Use of cyclooxygenase-2 inhibitors for producing medicaments useful for the prevention of cardiovascular disorders
AU2002211612A1 (en) Methods for the treatment of a traumatic central nervous system injury
EP1191941A4 (en) A method for the prophylaxis and/or treatment of medical disorders
HUP9877967A2 (en) Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
ZA958725B (en) Treatment of disorders with duloxetine
PL345769A1 (en) Triazolopyridines for the treatment of thrombosis disorders
HUP9702246A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of degenerative cerebral disorders
GB9303157D0 (en) Treatment of a group of related disorders
EP0689839A3 (en) Use of inhibitors of adenosine triphosphatase for the manufacture of a medicament for the treatment of disorders anociated with beta-amyloid peptide
IL126276A0 (en) The use of an inhibitor of the na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system
ZA988729B (en) The use of an inhibitor of the Na/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system
GB9419048D0 (en) Treatment of muscular disorders
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
ZA987781B (en) Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa
IL123422A0 (en) Use of 7alpha-methyl-17alpha-ethynyl-estrane derivatives for the manufacture of a medicament for the prophylaxis or the treatment of atherosclerosis
SI1061940T1 (en) Use of follistatin for the manufacture of a medicament for the treatment of muscle-related disorders
ZA981918B (en) Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
HUP0000679A3 (en) Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders